High-Risk Prostate Cancer Patient Data After Neoadjuvant Therapy

184 patients with locally high-risk prostate cancer received neoadjuvant therapy followed by radical prostatectomy. The dataset includes baseline clinical characteristics, treatment regimens, pathological response categories, biomarker measurements, and long-term outcomes. It was authored by Zhiyu Zhang and last updated on April 18, 2026.

Use Cases

• Predict biochemical recurrence based on pathological response categories and biomarker measurements.
• Analyze the association between treatment regimens and metastasis or overall survival.
• Model the progression to castration-resistant prostate cancer using baseline clinical characteristics.
• Evaluate androgen deprivation therapy dependence linked to inflammatory indices and Ki-67 measurements.

Strengths

• 184 patient records provide a focused cohort for analysis.
• Includes long-term outcomes such as metastasis and overall survival.
• Contains biomarker measurements like Ki-67 and inflammatory indices.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is 113.6 KB, indicating a limited scope.

Provenance

Source

Zhiyu Zhang

Freshness

Last updated 2026-04-18 16:48:29; freshness should be verified.